View Report Summary
View Report SummaryThe global therapeutic contact lenses market is expected to witness significant growth during the forecast period on account of growing ocular problems among the population, worldwide. Globally, around 2.2 billion people are suffering from vision impairment, out of which 1 billion have vision impairment that could have been prevented. Around 2.6 billion people are suffering from myopia, out of which 312 million are aged UNDER 19, and 1.8 billion population is suffering from presbyopia, according to WHO. Additionally, growing geriatric population is susceptible to various eye care diseases including age related macular degeneration, diabetic retinopathy, glaucoma, among others, which is further expected to fuel the market growth over the next few years.
The global therapeutic contact lens market is segmented based on material type, application, distribution channel. Based on material type, the market can be fragmented into Senofilcon, Balafilcon, Lotrafilcon, Methafilcon, Others (Etafilcon, Narafilcon, etc.). Based on application, the market can be divided into Drug Delivery, Corneal Healing, Pain Relief, Sealing & Protection, Others (Corneal Protection, etc.). Based on Distribution Channel, the market can be segmented Hospitals & Clinics, Online, Optical Retail Stores.
Regionally, Asia-Pacific region will register significant growth of around 9.38% during the forecast period. This can be ascribed to the growing geriatric population base in the region suffering from different ophthalmic problems especially in countries like China, India and Japan. Additionally, the prevalence of myopia has significantly increased among the children and youth in the region.
Alcon, Inc., CooperVision, Inc., Johnson & Johnson, Bausch, Health Companies, Inc., EssilorLuxottica S.A, Carl Zeiss Meditec AG, SynergEyes Inc., X-Cel Specialty Contacts, Hoya Corporation, SEED Co., Ltd. are among the major market players operating in the global therapeutic contact lens market.